EMA accepts GSK’s belantamab mafodotin application

3rd February 2020 Uncategorised 0

The drug was also accepted for accelerated assessment by the EMA’s Committee for Human Medicinal Products (CHMP).

More: EMA accepts GSK’s belantamab mafodotin application
Source: News